Category: Biotech

Direct Offering Lucite Deal Tombstone

Lucite deal tombstone marking a registered direct offering of stock by AlloVir. The clinical-stage cell therapy firm is based in Waltham, Massachusetts. (22AZH231)

2 Images
Side view of financial tombstone recognizing a registered direct offering of common stock.

Gene Therapy Lucite Tombstone

Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)

2 Images
Custom Lucite marking the acquisition of GeneTx, an Illinois-based developer of treatments for rare genetic disorders.

Live-Cell Imaging Deal Toy

Lucite deal toy commemorating the acquisition of CytoSMART, a Dutch firm specializing in live-cell imaging analysis. The acquirer, Axion BioSystems, is an Atlanta-based life sciences company. (22AZH106)

1 Image

Biopharma Stock Offering Tombstone

Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)

3 Images
Side view of crystal financial tombstone celebrating a direct offering of stock by Salarius Pharmaceuticals. (22AJH070) Back view of DNA strand-inspired financial tombstone marking an offering by clinical-stage firm Salarius Pharmaceuticals. (22AJH070)

Advanced Testing Laboratory Deal Toy

Lucite deal toy recognizing the acquisition of Cincinnati-based Advanced Testing Laboratory. ATL provides research and development services in such areas as life science, product safety, and analytical chemistry. (22AJH077)

1 Image

Pharmaceutical License Agreement Deal Toy

Lucite deal toy celebrating a license option agreement between Ironwood Pharmaceuticals and COUR, a biotech firm. The agreement centers on COUR’s therapy for PBC, a rare autoimmune disease affecting the liver.

(22ALJ081)
2 Images
Lucite deal toy recognizing a joint venture between Ironwood Pharmaceuticals and biotechnology firm COUR. The collaboration will allow Ironwood to develop and commercialize COUR's liver disease therapy CNP-104.

Radiopharm IPO Deal Toy

Crystal deal toy celebrating the initial public offering on the Australian Securities Exchange (ASX) of Radiopharm Theranostics. The Sydney-based company develops radiopharmaceutical drugs and treatments for cancer.

(21ALJ553)
2 Images
Crystal deal toy marking the ASX debut of Sydney-based biotech Radiopharm Theranostics.

Digital Therapeutics Deal Toy

Lucite deal toy, incorporating a spinning logo, celebrating growth capital provided to New York City-based Click Therapeutics. The debt financing will be used for the commercialization of several therapies, including one aimed at smoking cessation.

(21AKL594)
1 Image

Nasdaq IPO Deal Toy

Lucite deal toy celebrating the initial public offering (IPO) of Bluejay Diagnostics. The diagnostics and medical device firm is based in Acton, Massachusetts.

(21AKL655)
1 Image